Hear the generative AI journeys of Cohere, Epiq, and Forcura, including their market assessments, use case prioritization, responses to ethical and security considerations, while discussing generative AI's impact on healthcare, legal industries, and business applications.Topics Include:Panel Introductions by David CristiniWhere is Focura at in their AI journeySummary of Epiq’s AI journey to dateCohere’s AI journey to dateWhere did each company begin and assessing the market opportunitiesPrioritizing of use cases for EpiqFocura’s quick focus and results with generative AISimplifying healthcare and improving patient experience with generative AIHow do experiments and proof of concepts develop into production?Indicators that Cohere uses to identify customers ready to move fastUsecases that allows Forcura customers to move forwardGuidance on engaging the Executive Team – getting Executive alignmentHow are legal and healthcare customers responding to AI solutions and challengesChanges of priority from customer advisory panelsEvolving questions and concerns of functionality and dataSome customers reporting AI evaluation is slowing them downUsecases that are easier to start off with to gain trust and tractionDealing with AI concerns of ethics, security and privacy – managing objectionsUnderstanding ethics concerns – privacy can often be about where data residesCustomers often want “traceability”Accuracy and reducing hallucinations – AI comes with risk, business have to decide on business riskFuture facing – what are we excited about?Generative AI is excellent at translation services – ROI is excellentBusiness applications and social impact of generative AIParticipants:MaryAnn Wofford – VP of Sales, CoherePaul O'Hagan - Senior Director Product Management – AI Platform, EpiqAnnie Mueller Erstling – COO, ForcuraDavid Cristini - Director, ISV Sales North America, AWSSee how Amazon Web Services gives you the freedom to migrate, innovate, and scale your software company at https://aws.amazon.com/isv/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related